Syngene, Johns Hopkins Unite to Advance Early-Stage Drug Discovery - Contract Pharma
4 days ago • Google News
SYNGENE
NSEundefined 434.35-2.69%
Price Chart
Key Statistics
Market Cap
₹ 0
P/E Ratio
0.00
Revenue (TTM)
₹ 0
Volume
1.23M
52W High
₹ 0.00
52W Low
₹ 0.00
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
N/A
52 Week Low
N/A
About SYNGENE
No description available.
Employees
N/A
Headquarters
N/A
CEO
N/A
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg